• Economy
  • Investing
  • Editor’s Pick
  • Stock
Evil Shark Trades
Economy

Pentagon releases data on controversial abortion travel policy for service members

by March 27, 2024
by March 27, 2024

The Department of Defense has released partial data for its policy that covered travel expenses for service members seeking an abortion. 

The policy authorized administrative absences as well as travel and transportation allowances that gave service members and their dependents access to ‘non-covered reproductive healthcare.’ That includes non-covered abortion and assisted reproductive technology like in vitro fertilization, ovarian stimulations and egg retrieval. 

Per figures released Tuesday, this policy was used 12 times between June and December 2023, Deputy Pentagon press secretary Sabrina Singh said. 

The number accounts for how many times the policy was used, not how many people used it. Therefore, it could have been used several times by the same service member. 

In those 12 instances mentioned, the total cost paid by the Pentagon was slightly under $40,800. Singh did not disclose what specific non-covered reproductive healthcare services were used due to privacy concerns.

Singh said the DOD’s respective services were given an August deadline to submit data. Some were earlier than others, which accounts for no data being available from January to May 2023. 

The Biden administration introduced the policy in the wake of the Supreme Court’s ruling the summer prior that overturned Roe v. Wade. It proved controversial, igniting an uproar among Republican lawmakers who tried to kill it. 

In February 2023, Sen. Tommy Tuberville, R-Ala., embarked on a one-man crusade by blocking President Biden’s military nominations over what he described as the Pentagon’s ‘illegal’ policy of providing travel expense reimbursement to service members who seek an abortion. He finally ended his campaign in December. 

Fox News Digital’s Jamie Joseph contributed to this report.

This post appeared first on FOX NEWS
0 comment
0
FacebookTwitterPinterestEmail

previous post
Biden concedes to pro-Palestinian protesters after multiple interruptions: ‘They have a point’
next post
Pro-life groups assail FDA for ‘reckless disregard’ in Supreme Court abortion pill case

You may also like

Zelenskyy seeks ‘strong reaction’ from US if Putin...

Trump administration wins Supreme Court fight to slash...

Pentagon unveils new medal for troops deployed in...

Federal judge rules Trump appointee Alina Habba is...

‘Maine’s Mamdani’: Maine GOP chief issues warning about...

‘There are 50 swamps’: State Freedom Caucus Network...

Trump-aligned legal group probes Biden-era organ transplant program...

NATO defense chiefs stress commitment to Ukraine, discuss...

Russian drone crashes in Polish field; Warsaw protests...

Gabbard launches ‘ODNI 2.0,’ with plan to cut...

Enter Your Information Below To Receive Free Trading Ideas, Latest News And Articles.






    Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

    Recent Posts

    • Zelenskyy seeks ‘strong reaction’ from US if Putin is not ready for bilateral meeting
    • Trump administration wins Supreme Court fight to slash NIH medical research grants tied to DEI, LGBTQ studies
    • Pentagon unveils new medal for troops deployed in Trump’s southern border crackdown
    • Federal judge rules Trump appointee Alina Habba is unlawfully serving as US attorney
    • Walmart boosts sales outlook as it says tariff costs are rising

    Categories

    • Economy (7,095)
    • Editor's Pick (3,862)
    • Investing (2,826)
    • Stock (1,426)
    Email Whitelisting About Us Terms & Conditions Privacy Policy Contact Us

    Disclaimer: Evilsharktrades.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2024 EvilSharkTrades.com


    Back To Top
    Evil Shark Trades
    • Economy
    • Investing
    • Editor’s Pick
    • Stock